| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Legal > Copyright > Licensing Your Copyrighted Works |
|
Top Articles - Licensing Your Copyrighted Works
If you’ve taken the necessary steps to register your copyrighted works, you inevitably will have an opportunity to royalties off of them. According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product To take advantage of the opportunity, you will need to be familiar with copyright license agreements. Copyright License Agreement A co ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in pyright license agreement sets for the terms under which a third party can use your content. In legal language, you will the “licensor” w lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. th the other party being the “licensee.” The purpose of the agreement is to set forth the terms under which you, the licensor, will gran here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe t the third party, licensee, the right to use, publish or reuse your copyrighted work in exchange for a royalty. Let’s take a closer look d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro at key components of the licensing agreement. Specific Rights Granted This may sound obvious, but the agreement needs to detail exactly ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc what copyrighted material can be used. If you have copyrighted articles, are you granting a right to use all of the articles or only cer easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ain ones? It is highly recommended that the agreement contain a detailed description of the exact materials being covered. Once you agre nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e upon the exact materials, you need to determine any restrictions on how the material can be used. Can the material be used on the Inter and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ et or will it be restricted to a certain niche’ such as manuals or collections of materials? An extremely important issue is whether the ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi agreement grants exclusive or non-exclusive rights. In English, this simply defines whether the licensor can grant similar rights to oth ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a er parties. The grant of exclusive licenses should require a much larger royalty rate since you are essentially betting the third party w dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ll be successful. Licensing Royalties In exchange for your copyrighted work, the third party is going to make royalty payments to you. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin The particular amount of the royalty is dependent upon the nature of your work. Issues to consider include: 1) Will you be paid a flat a tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ount or percentage of sales? 2) If a percentage, will it be figured from gross revenues or something less? 3) How often will you be pai t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel d? 4) What rights will you have to audit the books of the third party to determine you are getting the full royalty? In some situations ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust you may decide to forgo a royalty payment. This usually occurs when the third party will use the materials in manner that produces massi y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ve publicity for you. For example, many professionals seek to right columns for publications as a marketing tool. Often, they will not ch . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de rge the publication for the material because the resulting publicity carries enough of a benefit. In Closing If you are considering lic elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ensing copyrighted content, keep the above in mind. Since such agreements are difficult to break, hiring an attorney is worth the expense tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Catching Someone Trying to Get Business Intelligence Tools To Make Web Marketing Easier
|